IHA Logo
IHA News

Follow us:

find_us_on_facebook
twitter
A A A

IHA News

Dr Nazif Alic paper published in Royal Society Proceedings B

Congratulations to Dr Nazif Alic whose paper has been published in the Royal Society's flagship biological research journal Proceedings B.
More...

Published: Dec 18, 2014 5:19:24 PM

Linda Partridge to speak at Nobel Week Dialogue, Live streaming and Q&A

Join in the digital discussion on ageing with IHA Director Linda Partridge as part of this year's Nobel Week Dialogue on 9th December.  More...

Published: Dec 4, 2014 11:04:44 AM

IHA Director Prof Linda Partridge honoured with BBSRC Excellence Award

IHA Director, Professor Linda Partridge, has been recognised with a BBSRC Anniversary Award for Excellence in Bioscience.

The Biotechnology and Biological Sciences Research Council (BBSRC) has recognised outstanding contributions to bioscience made by four of its research community. As part of BBSRC’s 20th anniversary, the awards demonstrate pride for the UK's world-leading bioscience research base and the impact it has achieved in the last two decades.

The awards will be presented at the Great British Bioscience Festival in November.

Professor Jackie Hunter, BBSRC Chief Executive, said: "Our 20th anniversary year is the perfect time to acknowledge and celebrate the achievements of researchers that BBSRC has supported. These awards highlight outstanding achievements that benefit us all and help to make the UK world-leading in bioscience."

Congratulations Linda!
More...

Published: Nov 7, 2014 4:31:19 PM

Fiona Kerr - Alzheimer's Association International Conference highlights

23 July 2012

Dr Fiona Kerr (Partridge Lab) attended the AAIC in Vancouver, 14th-19th July 2012 last week.

Fiona writes: Over the last three years Genome Wide Association Studies (GWAS) have led to the discovery of variants in 10 new genes which associate with increased risk of developing late-onset Alzheimer’s disease (LOAD). This has required an unprecedented level of collaboration within the AD field, pulling together clinical cohorts world-wide in order to achieve the large data-sets required to obtain meaningful findings in such studies. At this year’s AAIC the excitement re-instated in Alzheimer’s by this research was evident, with scientists looking toward the post-GWAS era of AD discovery. We need to understand more about the effect of these AD-risk variants on gene expression and function, and their potential role in the development of Alzheimer’s disease pathology. If any of these genes are found to play a causal role in AD pathogenesis, beyond simply associating with increased risk for disease development, this could uncover potential new therapeutic targets for the prevention and treatment of LOAD.

Page last modified on 23 jul 12 13:34